“…1 Nevertheless, little is known if these patients are really cured of their malignant disease, or the reported, admittedly improved survival rates are just consequences of an institutional selection bias, changing epidemiology of esophageal carcinoma, or in cases of early cancer, products of lead time bias and a short follow-up. [2][3][4] To minimize these biases and assess national temporal trends in long-term survival and possible cure rates in patients with carcinoma of the esophagus and the gastric cardia, we analyzed Surveillance, Epidemiology, and End Results (SEER) cancer registry data, comparing cancerrelated survival in each stage through the last 3 decades in the United States.…”